Navigation Links
Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences
Date:3/7/2008

Dr. Lin Mei, chief of developmental neurobiology at the Medical College of Georgia and Georgia Research Alliance Eminent Scholar in Neuroscience, has received the 2008 Mathilde Solowey Lecture Award in Neurosciences.

The annual award, administered by Foundation for Advanced Education in the Sciences, honors young or rising neuroscientists who excel in research that is cutting edge, translational and of broad importance.

Dr. Mei will discuss his studies of neural circuitry formation and synaptic plasticity, which have shed light on potential causes of schizophrenia and seizures as well as how certain neuromuscular diseases may occur, in a lecture May 15 at the National Institutes of Health in Bethesda, Md.

Dr. Mei and his colleagues study the function and underlying mechanism of neuregulin-1 and its receptor ErbB4 in neurotransmission. Both are important for neural development and have been implicated in schizophrenia. They discovered that the two proteins help keep a healthy balance between excitation and inhibition of brain cells. In 2007, Dr. Meis research, published in Neuron, showed that neuregulin-1 promotes inhibition at the site of inhibitory synapses in the brain by increasing release of GABA, a major inhibitory neurotransmitter.

In 2000, his research team showed neuregulin-1 suppresses excitation at excitatory synapses, communication points between neurons where the neurotransmitter glutamate excites cells to action. Both functions require ErbB4. The collective findings reveal a check and balance for brain cell activity managed by neuregulin-1 in the brains prefrontal cortex, the site of complex reasoning and decisions about appropriate social behavior. They also provide new treatment targets for psychiatric diseases such as schizophrenia and neurological disorders such as epilepsy.

He also studies how neurons and their target cells form contacts or synapses where signals are passed from one to the other
'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
2. Met-Pro Corporations Systems Division Receives Equipment Order Totaling Approximately $600,000
3. Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study
4. Endu Receives Gold Medal for Outstanding Chinese Patented Invention Award
5. Highlands Acquisition Corp. Receives Non-Compliance Letter From Amex
6. Vapotherm CEO Receives Top Business Leadership Award From World Trade Center Institute
7. Fujifilm Receives FDA Approval for Unity SpeedSuite(TM)
8. Bart De Strooper receives prestigious $200,000 Alzheimer Prize
9. The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units
10. Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation
11. Boca Pharmacal Receives FDA Approval for Carbinoxamine Oral Solution
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences
(Date:5/18/2013)... Utah (PRWEB) May 18, 2013 ... on insurance agents’ role in Marketplaces . ... to traditional employer sponsored health benefits, is the ... and health reimbursement arrangements . , ... Health and Human Services (HHS) recently released a ...
(Date:5/18/2013)... The “World Healthcare IT Market: Trends & Forecast (2010 ... restraints, and opportunities in North America, Europe, Asia, & ... 89 market data tables , ... , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early buyers ... healthcare IT market is expected to grow from $99.6 ...
(Date:5/18/2013)... York, New York (PRWEB) May 18, 2013 ... to mount in courts throughout the country, Bernstein Liebhard ... metal-on-metal hip replacement patients often suffer tissue damage before ... the study, which according to Science Daily will appear ... metal-on-metal hip replacement recipients underwent MRI screens of their ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices ... Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user ... studies the major market drivers, restraints, and opportunities in ... , Browse , 147 market ... , 318 pagesand in-depth TOC of ...
(Date:5/18/2013)... The Ayurvedic practitioner program will be offered ... West. Program is available in Mexico via Live Internet ... modality practiced for over 5,000 years. In Ayurvedic medicine ... begins when an individual lives in harmony with their ... Ayurveda aims to heal an individual in all levels ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2
... 29 Varian Medical,Systems (NYSE: VAR ) ... equipment for a major new hospital in,Portsmouth, England. ... the investment waves of the UK government,s Cancer ... will receive four high-energy,Clinac(R) iX linear accelerators equipped ...
... American Legacy Foundation(R) Finds Tobacco-Free,States Spend Less on ... could spend nearly $10 billion less within five ... new study released today by the,American Legacy Foundation ... cut Medicaid costs by 5.6 percent., The ...
... of the hip is a growing problem that will ... have reported on risk factors for developing OA, but ... prognosis. A new study published in the December issue ... patients with hip pain to determine their disease progression ...
... (NYSE:,CNO) said today that it has agreed to implement a ... (LTCG) for certain,back-office functions of the long term care business ... year that it was,considering this solution. Under the agreement:, ... call center and the processing ...
... Nov. 29, WASHINGTON, Nov. 28 The following ... WHAT: A press briefing by conference call with experts ... as recently issued,proposals by several of the candidates for ... the new estimates of the AIDS crisis mean for ...
... in a key piece of DNA seem important, scientists say ... contribute to disparities in colorectal cancer rates between ethnic and ... team, led by investigators at the University of Pittsburgh, analyzed ... found that people who have two "T" copies of the ...
Cached Medicine News:Health News:Varian Image-Guided Treatment Machines Selected for Major New Hospital on South Coast of England 2Health News:Varian Image-Guided Treatment Machines Selected for Major New Hospital on South Coast of England 3Health News:Smokers Cost Medicaid System Nearly $10 Billion 2Health News:Smokers Cost Medicaid System Nearly $10 Billion 3Health News:Identifying patients at high risk for total hip replacement 2Health News:Conseco to Implement Systems and Operational Solution From Long Term Care Group 2Health News:Conseco to Implement Systems and Operational Solution From Long Term Care Group 3Health News:Conseco to Implement Systems and Operational Solution From Long Term Care Group 4Health News:Conseco to Implement Systems and Operational Solution From Long Term Care Group 5Health News:Genes May Explain Role of Race in Colon Cancer Risk 2
(Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology Inc. ... Sorter 8-well strip holder and 130um sorting chip.  Sony will ... collected on its new SH800 Cell Sorter, the EC800 flow ... commercial tutorials at CYTO 2013, which will be held at ... San Diego, California , from May 20 ...
(Date:5/17/2013)... 2013  TechAtlas Group has announced the release ... map for the Chronic Kidney Disease (CKD) market. ... with drugs and devices currently on the market ... (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... - renal denervation , diabetic nephropathy - ...
(Date:5/17/2013)... Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) ... new, patent-pending technologies poised to redefine how consumers receive energy, ... a business update teleconference and webcast for shareholders and the ... 4:30 PM ET. Fuse Science, Inc. CEO, ... and will be joined by Rubin Hanan ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ... affiliate of Vanda,s sublicensor Novartis Pharma AG, has ... injectable (or depot) formulation of Fanapt® (iloperidone).  This ... the safety and pharmacokinetic profiles of two different ...
... ROME, April 8, 2011 Noverca – the first and ... offerings by announcing its presence in the Health and ... to support diabetes treatment has been developed and launched thanks ... of N o verca) and Fatebenefratelli ...
Cached Medicine Technology:Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 2Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 3EXTENDED HEALTH: Noverca Enters the World of Healthcare 2
... single use, disposable device that is specifically ... after the needle is in place. ,It ... from accidental movement by contact, during patient ... patient confidence in your staff and your ...
... for high volume laboratories, the AU2700 automates ... time. This high-speed analyzer delivers true random ... test results per hour (up to 2133 ... tests on-board. Consolidate with Olympus 122 test ...
... The EPO ELISA is intended for the ... This assay is intended for in vitro diagnostic ... anemias and polycythemias. With the advent of the ... to increase red blood cell mass, an erythropoietin ...
... innovative PoleStar N20, exclusively distributed by ... MRI. Combining intra-operative imaging with ... system, PoleStar N20 is one of ... today. , , Exceptional image quality ...
Medicine Products: